HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lan Zhang Selected Research

karyopherin alpha 2

1/2018KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducing epithelial-mesenchymal transition via Akt/GSK-3β/Snail activation.
6/2017KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
9/2015MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lan Zhang Research Topics

Disease

129Neoplasms (Cancer)
06/2022 - 07/2005
39Hepatocellular Carcinoma (Hepatoma)
11/2021 - 10/2009
31Inflammation (Inflammations)
06/2022 - 05/2010
24Neoplasm Metastasis (Metastasis)
01/2022 - 08/2005
23Alzheimer Disease (Alzheimer's Disease)
02/2022 - 10/2006
19Breast Neoplasms (Breast Cancer)
04/2022 - 05/2011
17Ischemic Stroke
01/2021 - 03/2009
16Infections
10/2022 - 02/2009
15Stroke (Strokes)
06/2022 - 04/2006
14Ischemia
01/2019 - 02/2005
12Carcinogenesis
10/2022 - 07/2010
12Brain Ischemia (Cerebral Ischemia)
12/2019 - 05/2010
11Stomach Neoplasms (Stomach Cancer)
01/2022 - 01/2015
10Esophageal Squamous Cell Carcinoma
08/2021 - 08/2005
9Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 11/2014
9Cognitive Dysfunction
01/2022 - 09/2006
9Parkinson Disease (Parkinson's Disease)
01/2022 - 04/2008
9Carcinoma (Carcinomatosis)
01/2021 - 07/2005
8Memory Disorders (Memory Loss)
02/2022 - 10/2006
8Infarction (Infarctions)
01/2021 - 05/2010
8Lung Neoplasms (Lung Cancer)
01/2021 - 03/2012
8Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 09/2012
8Hypertension (High Blood Pressure)
12/2018 - 01/2011
7Triple Negative Breast Neoplasms
04/2022 - 11/2015
7AIDS-Related Complex (ARC)
03/2022 - 07/2011
7Lymphatic Metastasis
02/2022 - 01/2012
7Melanoma (Melanoma, Malignant)
01/2022 - 06/2007
7Pain (Aches)
01/2022 - 06/2010
7Necrosis
04/2021 - 10/2011
7Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 07/2005
7Cardiovascular Diseases (Cardiovascular Disease)
10/2020 - 03/2009
7Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 05/2013
6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2009
6Liver Neoplasms (Liver Cancer)
02/2021 - 10/2012
6Osteoporosis
02/2020 - 10/2011
6Hypoxia (Hypoxemia)
01/2019 - 10/2007
5Neuroinflammatory Diseases
01/2023 - 10/2012
5Thrombosis (Thrombus)
01/2022 - 12/2012
5Schizophrenia (Dementia Praecox)
01/2022 - 03/2009
5Fibrosis (Cirrhosis)
12/2021 - 08/2012
5Demyelinating Diseases (Demyelinating Disease)
01/2021 - 10/2012
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 07/2010
5Cataract (Cataracts)
10/2020 - 08/2010
5Reperfusion Injury
11/2019 - 01/2007
5Neuroblastoma
07/2015 - 02/2010
4Sepsis (Septicemia)
11/2022 - 05/2007
4Body Weight (Weight, Body)
11/2022 - 04/2007
4Birth Weight (Birth Weights)
01/2022 - 02/2010

Drug/Important Bio-Agent (IBA)

59Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2005
34Pharmaceutical PreparationsIBA
06/2022 - 10/2004
34Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2012
25MicroRNAs (MicroRNA)IBA
01/2022 - 03/2014
23Biological ProductsIBA
02/2022 - 07/2005
16Messenger RNA (mRNA)IBA
01/2022 - 07/2005
14CytokinesIBA
06/2022 - 02/2005
13Long Noncoding RNAIBA
01/2022 - 01/2017
12EnzymesIBA
10/2020 - 03/2010
11GlycosidesIBA
10/2021 - 05/2010
10IridoidsIBA
01/2021 - 05/2010
10DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2012
8AntioxidantsIBA
01/2022 - 09/2012
8Glucose (Dextrose)FDA LinkGeneric
12/2021 - 01/2008
8AlbuminsIBA
11/2021 - 09/2014
8Neuroprotective AgentsIBA
10/2021 - 01/2007
8CateninsIBA
01/2021 - 01/2015
8salicylhydroxamic acid (SHAM)IBA
01/2018 - 09/2012
7Amyloid (Amyloid Fibrils)IBA
04/2021 - 08/2012
7Peptides (Polypeptides)IBA
10/2019 - 11/2009
7Therapeutic UsesIBA
09/2019 - 04/2006
6AntigensIBA
01/2022 - 10/2007
6CholesterolIBA
05/2021 - 01/2011
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2008
6Phosphotransferases (Kinase)IBA
04/2020 - 04/2015
6Nerve Growth Factors (Neurotrophins)IBA
03/2020 - 09/2006
6Transcription Factors (Transcription Factor)IBA
11/2019 - 08/2008
6alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2019 - 10/2012
5BilirubinIBA
06/2022 - 01/2015
5Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2017
5Docetaxel (Taxotere)FDA Link
01/2022 - 03/2013
5Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 07/2013
5Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2021 - 01/2014
52',3',4',5'- tetrahydroxystilbene- 2- O- beta- D- glucosideIBA
04/2021 - 10/2006
5RNA (Ribonucleic Acid)IBA
01/2021 - 05/2011
5MicellesIBA
05/2018 - 03/2013
5Streptozocin (Streptozotocin)FDA Link
05/2018 - 11/2011
5ChemokinesIBA
04/2016 - 06/2009
4VaccinesIBA
10/2022 - 01/2016
4LipidsIBA
01/2022 - 04/2002
4SincalideFDA Link
01/2022 - 09/2019
4Fluorouracil (Carac)FDA LinkGeneric
11/2021 - 03/2006

Therapy/Procedure

64Therapeutics
05/2022 - 04/2006
19Drug Therapy (Chemotherapy)
02/2022 - 04/2002
12Radiofrequency Ablation
01/2021 - 01/2014
7Aftercare (After-Treatment)
01/2022 - 10/2012
7Radiotherapy
11/2021 - 12/2012
7Transplantation
01/2021 - 04/2008
5Induced Hyperthermia (Thermotherapy)
11/2021 - 01/2013
5Immunotherapy
01/2021 - 10/2007
5Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2020 - 01/2016
4Chemoradiotherapy
02/2022 - 01/2021